Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Douglas Scharre
76 participants
Aug 30, 2018
OBSERVATIONAL
Conditions
Summary
The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A functional imaging of the dopamine transporter using the radioligand \[123I\]FP-CIT
A brain scan to to measure the extent of amyloid deposition
a brain scan measuring total and regional cerebral glucose metabolism wtih positron emission tomographs with 2-(18F)
10 ml of whole blood will be drawn and shipped to Athena Diagnostics for genetic testing.
Overnight sleep study
Clinical assessments include cognitive, behavioral, and motor evaluations
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03019757